MARE2_HUMAN - dbPTM
MARE2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MARE2_HUMAN
UniProt AC Q15555
Protein Name Microtubule-associated protein RP/EB family member 2
Gene Name MAPRE2
Organism Homo sapiens (Human).
Sequence Length 327
Subcellular Localization Cytoplasm, cytoskeleton . Associated with the microtubule network. Accumulates at the plus end of microtubules.
Protein Description May be involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. May play a role in cell migration (By similarity)..
Protein Sequence MPGPTQTLSPNGENNNDIIQDNNGTIIPFRKHTVRGERSYSWGMAVNVYSTSITQETMSRHDIIAWVNDIVSLNYTKVEQLCSGAAYCQFMDMLFPGCISLKKVKFQAKLEHEYIHNFKLLQASFKRMNVDKVIPVEKLVKGRFQDNLDFIQWFKKFYDANYDGKEYDPVEARQGQDAIPPPDPGEQIFNLPKKSHHANSPTAGAAKSSPAAKPGSTPSRPSSAKRASSSGSASKSDKDLETQVIQLNEQVHSLKLALEGVEKERDFYFGKLREIELLCQEHGQENDDLVQRLMDILYASEEHEGHTEEPEAEEQAHEQQPPQQEEY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2 (in isoform 5)Acetylation-58.4322814378
5Phosphorylation---MPGPTQTLSPNG
---CCCCCCCCCCCC
39.8529255136
7Phosphorylation-MPGPTQTLSPNGEN
-CCCCCCCCCCCCCC
31.5123401153
9PhosphorylationPGPTQTLSPNGENNN
CCCCCCCCCCCCCCC
21.5123401153
25PhosphorylationIIQDNNGTIIPFRKH
CEECCCCCEEECCCC
20.1826074081
33PhosphorylationIIPFRKHTVRGERSY
EEECCCCEECCEECC
18.22-
39PhosphorylationHTVRGERSYSWGMAV
CEECCEECCEEEEEE
21.1529978859
40PhosphorylationTVRGERSYSWGMAVN
EECCEECCEEEEEEE
18.0529978859
41PhosphorylationVRGERSYSWGMAVNV
ECCEECCEEEEEEEE
20.5729978859
49PhosphorylationWGMAVNVYSTSITQE
EEEEEEEEECCCCHH
10.8829978859
50PhosphorylationGMAVNVYSTSITQET
EEEEEEEECCCCHHH
16.0528851738
51PhosphorylationMAVNVYSTSITQETM
EEEEEEECCCCHHHH
13.3727732954
52PhosphorylationAVNVYSTSITQETMS
EEEEEECCCCHHHHC
20.0727732954
54PhosphorylationNVYSTSITQETMSRH
EEEECCCCHHHHCHH
21.8128851738
57PhosphorylationSTSITQETMSRHDII
ECCCCHHHHCHHHHH
15.6128851738
59PhosphorylationSITQETMSRHDIIAW
CCCHHHHCHHHHHHH
33.6128851738
76UbiquitinationDIVSLNYTKVEQLCS
HHHCCCCCCHHHHHC
27.78-
83UbiquitinationTKVEQLCSGAAYCQF
CCHHHHHCCHHHHHH
39.81-
89UbiquitinationCSGAAYCQFMDMLFP
HCCHHHHHHHHHHCC
24.83-
95UbiquitinationCQFMDMLFPGCISLK
HHHHHHHCCCCEEEC
3.82-
98UbiquitinationMDMLFPGCISLKKVK
HHHHCCCCEEECEEE
1.62-
102UbiquitinationFPGCISLKKVKFQAK
CCCCEEECEEEEEEE
49.0521890473
109AcetylationKKVKFQAKLEHEYIH
CEEEEEEECCCHHHH
43.5626051181
109UbiquitinationKKVKFQAKLEHEYIH
CEEEEEEECCCHHHH
43.56-
112UbiquitinationKFQAKLEHEYIHNFK
EEEEECCCHHHHHHH
43.53-
113UbiquitinationFQAKLEHEYIHNFKL
EEEECCCHHHHHHHH
36.49-
119UbiquitinationHEYIHNFKLLQASFK
CHHHHHHHHHHHHHH
54.31-
119AcetylationHEYIHNFKLLQASFK
CHHHHHHHHHHHHHH
54.3125953088
122UbiquitinationIHNFKLLQASFKRMN
HHHHHHHHHHHHHCC
45.45-
124PhosphorylationNFKLLQASFKRMNVD
HHHHHHHHHHHCCCC
20.5230108239
126AcetylationKLLQASFKRMNVDKV
HHHHHHHHHCCCCCE
48.5225953088
126MalonylationKLLQASFKRMNVDKV
HHHHHHHHHCCCCCE
48.5226320211
126UbiquitinationKLLQASFKRMNVDKV
HHHHHHHHHCCCCCE
48.52-
132UbiquitinationFKRMNVDKVIPVEKL
HHHCCCCCEEEHHHH
37.47-
138AcetylationDKVIPVEKLVKGRFQ
CCEEEHHHHHCCCCC
59.8325953088
138UbiquitinationDKVIPVEKLVKGRFQ
CCEEEHHHHHCCCCC
59.83-
141UbiquitinationIPVEKLVKGRFQDNL
EEHHHHHCCCCCCCC
55.60-
143UbiquitinationVEKLVKGRFQDNLDF
HHHHHCCCCCCCCHH
21.9721890473
143UbiquitinationVEKLVKGRFQDNLDF
HHHHHCCCCCCCCHH
21.9721890473
151UbiquitinationFQDNLDFIQWFKKFY
CCCCCHHHHHHHHHH
3.37-
155 (in isoform 1)Ubiquitination-38.7321890473
155 (in isoform 2)Ubiquitination-38.7321890473
155UbiquitinationLDFIQWFKKFYDANY
CHHHHHHHHHHCCCC
38.7321890473
156UbiquitinationDFIQWFKKFYDANYD
HHHHHHHHHHCCCCC
39.42-
158PhosphorylationIQWFKKFYDANYDGK
HHHHHHHHCCCCCCC
24.0329496907
162PhosphorylationKKFYDANYDGKEYDP
HHHHCCCCCCCCCCC
28.0029978859
165UbiquitinationYDANYDGKEYDPVEA
HCCCCCCCCCCCCHH
50.64-
165SumoylationYDANYDGKEYDPVEA
HCCCCCCCCCCCCHH
50.64-
167PhosphorylationANYDGKEYDPVEARQ
CCCCCCCCCCCHHCC
29.0925159151
193UbiquitinationEQIFNLPKKSHHANS
HHHCCCCCCCCCCCC
70.81-
194UbiquitinationQIFNLPKKSHHANSP
HHCCCCCCCCCCCCC
53.75-
195PhosphorylationIFNLPKKSHHANSPT
HCCCCCCCCCCCCCC
26.9929691806
200PhosphorylationKKSHHANSPTAGAAK
CCCCCCCCCCCCCCC
25.1425159151
202PhosphorylationSHHANSPTAGAAKSS
CCCCCCCCCCCCCCC
37.2328176443
207UbiquitinationSPTAGAAKSSPAAKP
CCCCCCCCCCCCCCC
51.43-
208PhosphorylationPTAGAAKSSPAAKPG
CCCCCCCCCCCCCCC
36.5123401153
209PhosphorylationTAGAAKSSPAAKPGS
CCCCCCCCCCCCCCC
20.1825159151
213UbiquitinationAKSSPAAKPGSTPSR
CCCCCCCCCCCCCCC
52.60-
213AcetylationAKSSPAAKPGSTPSR
CCCCCCCCCCCCCCC
52.6025953088
216PhosphorylationSPAAKPGSTPSRPSS
CCCCCCCCCCCCCCC
45.7523401153
216O-linked_GlycosylationSPAAKPGSTPSRPSS
CCCCCCCCCCCCCCC
45.7528411811
217PhosphorylationPAAKPGSTPSRPSSA
CCCCCCCCCCCCCCC
31.0625159151
218UbiquitinationAAKPGSTPSRPSSAK
CCCCCCCCCCCCCCC
30.0021890473
219PhosphorylationAKPGSTPSRPSSAKR
CCCCCCCCCCCCCCC
57.8425159151
222PhosphorylationGSTPSRPSSAKRASS
CCCCCCCCCCCCCCC
41.6425159151
223PhosphorylationSTPSRPSSAKRASSS
CCCCCCCCCCCCCCC
40.2625159151
225AcetylationPSRPSSAKRASSSGS
CCCCCCCCCCCCCCC
50.9012435305
228AcetylationPSSAKRASSSGSASK
CCCCCCCCCCCCCCC
29.12-
228UbiquitinationPSSAKRASSSGSASK
CCCCCCCCCCCCCCC
29.12-
228PhosphorylationPSSAKRASSSGSASK
CCCCCCCCCCCCCCC
29.1226657352
229PhosphorylationSSAKRASSSGSASKS
CCCCCCCCCCCCCCC
37.4223401153
230PhosphorylationSAKRASSSGSASKSD
CCCCCCCCCCCCCCC
33.9829978859
232PhosphorylationKRASSSGSASKSDKD
CCCCCCCCCCCCCHH
31.1728464451
234PhosphorylationASSSGSASKSDKDLE
CCCCCCCCCCCHHHH
34.1018669648
235UbiquitinationSSSGSASKSDKDLET
CCCCCCCCCCHHHHH
63.49-
236PhosphorylationSSGSASKSDKDLETQ
CCCCCCCCCHHHHHH
47.6128464451
238AcetylationGSASKSDKDLETQVI
CCCCCCCHHHHHHHH
71.8925953088
238UbiquitinationGSASKSDKDLETQVI
CCCCCCCHHHHHHHH
71.89-
242PhosphorylationKSDKDLETQVIQLNE
CCCHHHHHHHHHHHH
35.1228464451
253PhosphorylationQLNEQVHSLKLALEG
HHHHHHHHHHHHHHH
28.4830576142
255UbiquitinationNEQVHSLKLALEGVE
HHHHHHHHHHHHHHH
34.43-
259UbiquitinationHSLKLALEGVEKERD
HHHHHHHHHHHHHHH
56.4321890473
259UbiquitinationHSLKLALEGVEKERD
HHHHHHHHHHHHHHH
56.4321890473
263UbiquitinationLALEGVEKERDFYFG
HHHHHHHHHHHCHHH
56.49-
263AcetylationLALEGVEKERDFYFG
HHHHHHHHHHHCHHH
56.4925953088
271AcetylationERDFYFGKLREIELL
HHHCHHHHHHHHHHH
34.1823236377
271UbiquitinationERDFYFGKLREIELL
HHHCHHHHHHHHHHH
34.1821890473
271 (in isoform 1)Ubiquitination-34.1821890473
327PhosphorylationQPPQQEEY-------
CCCCCCCC-------
24.0927642862

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
236SPhosphorylationKinaseCSNK2A1P68400
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MARE2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MARE2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NIF3L_HUMANNIF3L1physical
16189514
MARE2_HUMANMAPRE2physical
16189514
MARE3_HUMANMAPRE3physical
16189514
APC_HUMANAPCphysical
11470413
A4_HUMANAPPphysical
21832049
MARE2_HUMANMAPRE2physical
25416956
MARE1_HUMANMAPRE1physical
25416956
PAXI1_HUMANPAXIP1physical
25416956
THIOM_HUMANTXN2physical
25416956
CRAC1_HUMANCRTAC1physical
25416956
MCM6_HUMANMCM6physical
26344197
HSF1_HUMANHSF1physical
27173435
TC1D2_HUMANTCTEX1D2physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MARE2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-271, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208 AND SER-219, ANDMASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219 AND SER-223, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-167, AND MASSSPECTROMETRY.

TOP